Skip to content
etfnews.live

Company

Ascendis Pharma

ASND · Denmark

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Ascendis Pharma?

Held by 70 covered funds. Sorted by Ascendis Pharma’s share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
MEDIHarbor Health Care13.6%
AADRAdvisorShares Dorsey Wright ADR3.2%
SPYGXSpyglass Growth Fund3.1%
AFOSARS Focused Opportunities Strategy3.0%
SQSSapient Quality Select2.6%
FDGAmerican Century Focused Dynamic Growth2.5%
EXUSNomura Focused International Core2.2%
FMEDFidelity Disruptive Medicine2.0%
TMEDT. Rowe Price Health Care1.6%
WEGRXAllspring Emerging Growth Fund1.6%
BBPVirtus LifeSci Biotech Products1.5%
THMEXCCT Thematic Equity Fund1.4%
IBBiShares Biotechnology1.3%
TCAFT. Rowe Price Capital Appreciation Equity1.3%
FFOGFranklin Focused Growth1.1%
IBBQInvesco Nasdaq Biotechnology1.1%
QOWZInvesco Nasdaq Free Cash Flow Achievers1.1%
ILDRFirst Trust Innovation Leaders1.0%
FMEFXNuveen Small/Mid Cap Growth Opportunities Fund1.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.9%
HRTSTema Heart & Health0.8%
QQMGInvesco NASDAQ Next Gen 1000.6%
QQQJInvesco Nasdaq Next Gen 1000.6%
JDOCJPMorgan Healthcare Leaders0.6%
TCALT. Rowe Price Capital Appreciation Premium Income0.6%
FPXEFirst Trust IPOX Europe Equity Opportunities0.4%
TMSLT. Rowe Price Small-Mid Cap0.3%
IWPiShares Russell Mid-Cap Growth0.3%
WDAIPacer S&P World 3AI Top 3000.3%
BRSMMFS Blended Research Small-Mid Cap0.3%
FSOPXFidelity Series Small Cap Opportunities Fund0.3%
ESIMEventide International0.3%
IDHQInvesco S&P International Developed Quality0.2%
TNXTT. Rowe Price Innovation Leaders0.2%
IYHiShares U.S. Healthcare0.2%
FSBDXFidelity Series Blue Chip Growth Fund0.2%
FOTHXFidelity OTC Portfolio0.2%
FOKFXFidelity OTC K6 Portfolio0.1%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.1%
RUSCU.S. Small Cap Equity Active0.1%
REMCColumbia Research Enhanced Mid Cap0.1%
FBCCXFidelity Blue Chip Growth Fund0.1%
IWRiShares Russell Mid-Cap0.1%
QQHGInvesco QQQ Hedged Advantage0.1%
GLOVGoldman Sachs ActiveBeta(R) World Low Vol Plus Equity0.1%
IQSINYLI Candriam International Equity0.1%
FBCGXFidelity Blue Chip Growth K6 Fund0.1%
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid0.1%
GSIDGoldman Sachs MarketBeta International Equity0.1%
BDVLiShares Disciplined Volatility Equity Active0.1%
MNZLManzil Russell Halal USA Broad Market0.1%
VDGVanguard Developed Markets Ex-US Growth Index0.0%
BKIEBNY Mellon International Equity0.0%
GGUSGoldman Sachs MarketBeta(R) Russell 1000 Growth Equity0.0%
SPDWSPDR Portfolio Developed World ex- US0.0%
IWFiShares Russell 1000 Growth0.0%
VDVVanguard Developed Markets Ex-US Value Index0.0%
GXUSGoldman Sachs MarketBeta Total International Equity0.0%
ONEQFidelity Nasdaq Composite Index0.0%
ONEOState Street(R) SPDR(R) Russell 1000 Momentum Focus0.0%
IWBiShares Russell 10000.0%
IWViShares Russell 30000.0%
RECSColumbia Research Enhanced Core0.0%
VTCIXVanguard Tax-Managed Capital Appreciation Fund0.0%
DEUSXtrackers Russell US Multifactor0.0%
IWSiShares Russell Mid-Cap Value0.0%
FBCGFidelity Blue Chip Growth0.0%
IWDiShares Russell 1000 Value0.0%
REVSColumbia Research Enhanced Value0.0%
VGIAXVanguard Growth and Income Fund0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Ascendis Pharma news